2016
DOI: 10.1021/acs.molpharmaceut.6b00929
|View full text |Cite
|
Sign up to set email alerts
|

Biodistribution of Self-Assembling Polymer–Gemcitabine Conjugate after Systemic Administration into Orthotopic Pancreatic Tumor Bearing Mice

Abstract: Therapeutic efficacy of gemcitabine (GEM) is severely limited due to its rapid metabolism by enzymatic deamination in vivo. We recently determined its therapeutic efficacy before (F-GEM) and after conjugation to poly(ethylene glycol)-block-poly(2-methyl-2-carboxyl-propylene carbonate) (mPEG-b-PCC-g-GEM-g-DC, abbreviated as P-GEM) in subcutaneous and orthotopic pancreatic tumor bearing mice. In this study, pharmacokinetic (PK) parameters and biodistribution profiles of F-GEM and P-GEM were determined after intr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
23
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 28 publications
(25 citation statements)
references
References 34 publications
1
23
1
Order By: Relevance
“…In addition to the induction of chemoresistance [3], GEM effectiveness is also restricted due to its rapid plasma metabolism requiring high dose resulting in systemic toxicity [23]. However, the use of appropriate nano-formulations has shown to overcome these bottlenecks.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…In addition to the induction of chemoresistance [3], GEM effectiveness is also restricted due to its rapid plasma metabolism requiring high dose resulting in systemic toxicity [23]. However, the use of appropriate nano-formulations has shown to overcome these bottlenecks.…”
Section: Discussionmentioning
confidence: 99%
“…However, the use of appropriate nano-formulations has shown to overcome these bottlenecks. For instance, in our earlier studies, we have demonstrated mPEG-b-PCC-g-GEM-g-DC polymer improves the stability, loading and accumulation of GEM in the pancreatic tumor [23,24]. However, unlike intratumoral administration of polymeric micelles containing miR-205 mimic and GEM in subcutaneous tumor model which lack original tumor microenvironment and clinically infeasible [20], in this study, we administered mPEG-b-PCC-g-GEM-g-DC micelles intravenously in orthotopic pancreatic tumor-bearing mice.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Therefore, in this study, we conjugated DTX and CYP to a biodegradable amphiphilic diblock copolymer mPEG-b-PCC with pendant carboxyl acid groups. We previously conjugated a water soluble drug gemcitabine as well as dodecanol to mPEG-b-PCC, which self-assembled into micelles and showed enhaced drug delivery to pancreatic tumor, which resulted in significant reduction in tumor growth [2022]. In this study, DTX was conjugated to mPEG-b-PCC through an ester bond at its 2′-OH position.…”
Section: Discussionmentioning
confidence: 99%
“…Kattle et al. determined PK parameters and biodistribution profiles of mPEG‐b‐PCC‐g‐GEM‐g‐DC and free GEM after intravenous injection into MIA PaCa‐2 cell derived orthotopic pancreatic tumor bearing NSG mice and observed that mPEG‐b‐PCC‐g‐GEM‐g‐DC enhanced 2.5‐fold GEM accumulation in the tumor than free GEM with no obvious toxicity . Mondal et al.…”
Section: Nanocarriersmentioning
confidence: 99%